Standard Biotools | FLDM - Assets


Standard Biotools reported $639.11M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Agilent USD 13.07B 252M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Bio-Rad Laboratories USD 10.25B 462M Jun/2026
Bruker USD 6.05B 77.8M Jun/2026
Danaher USD 92.37B 8.82B Jun/2026
Illumina USD 6.65B 91M Jun/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
Nikon Corporation JPY 1.08T 24.82B Mar/2026
Pacific Biosciences Of California USD 782.36M 1.72M Mar/2026
Revvity USD 12.05B 49.24M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sony JPY 16.05T 363.81B Jun/2026
Standard Biotools USD 639.11M 71.36M Mar/2026
Thermo Fisher Scientific USD 113.17B 107M Jun/2026
Waters USD 24.75B 220M Jun/2026